Month: July 2021

AUSTIN, Texas, July 26, 2021 (GLOBE NEWSWIRE) — Asure (Nasdaq: ASUR), a leading provider of cloud-based Human Capital Management (HCM) software solutions, today announced that its financial results for the second quarter of 2021 will be released after the market close on Monday, August 9, 2021. Asure will host a conference call to discuss the results at 3:30pm CT (4:30pm ET) on the same day. Asure Chairman and CEO Pat Goepel as well as CFO John Pence will host the conference call, followed by a question and answer session. Date: Monday, August 9, 2021Time: 3:30 p.m. Central time (4:30 p.m. Eastern time)U.S. dial-in: (877) 853-5636International dial-in: (631) 291-4544Conference ID: 1138654A live webcast, as well as a replay, will be available on the Company’s investor relations website at: https://investor.asuresoftware.com/events-and-presentations. About...

MCLEAN, Va., July 26, 2021 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today posted to its website its Monthly Volume Summary for June 2021, which provides information on Freddie Mac’s mortgage-related portfolios, securities issuance, risk management, delinquencies, debt activities, and other investments. Freddie Mac makes home possible for millions of families and individuals by providing mortgage capital to lenders. Since our creation by Congress in 1970, we’ve made housing more accessible and affordable for homebuyers and renters in communities nationwide. We are building a better housing finance system for homebuyers, renters, lenders, and taxpayers. Learn more at FreddieMac.com, Twitter @FreddieMac, and Freddie Mac’s blog FreddieMac.com/blog. MEDIA CONTACT: Fred Solomon703-903-3861Frederick_Solomon@freddiemac.comINVESTOR...

REDWOOD CITY, Calif., July 26, 2021 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that its second quarter 2021 financial results will be released after market close on Thursday, August 5, 2021. Starting at 5 p.m. ET, Coherus’ management team will host a conference call and webcast to discuss financial results and provide a general business update. After releasing second quarter financial results, the Company will post them on the Coherus website at https://investors.coherus.com. Conference Call Information When: Thursday, August 5, 2021 starting at 5:00 p.m. ET Dial-in: (844) 452-6826 (Toll-Free U.S. and Canada) or (765) 507-2587 (International) Conference ID: 9146617 Webcast: https://investors.coherus.com/upcoming-events Please dial-in 15 minutes early to ensure a timely connection to...

BOSTON, July 26, 2021 (GLOBE NEWSWIRE) — Ziopharm Oncology, Inc. (Nasdaq: ZIOP), today announced that management will host a conference call and webcast on Monday, August 9, at 4:30 p.m. EDT to provide a corporate update and discuss financial results for the second quarter ended June 30, 2021. The conference call can be accessed by dialing 877-451-6152 (U.S. and Canada) or 201-389-0879 (International). The passcode for the conference call is 13721210. A live webcast may be accessed using the link here, or by visiting the “Investors” section of the Ziopharm website at www.ziopharm.com. The call will be recorded and available for replay on the Company’s website for approximately 90 days after the call. About Ziopharm Oncology, Inc.Ziopharm is developing non-viral and cytokine-driven cell and gene therapies that weaponize the body’s...

AUSTIN, Texas, July 26, 2021 (GLOBE NEWSWIRE) — Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced that Mark Bach, M.D., Ph.D., accepted his appointment to the Company’s Clinical Scientific Advisory Board (CSAB) effective July 15, 2021. Dr. Bach joins the Company’s accomplished advisory board comprised of noted pediatric endocrinologists, Peter Clayton, M.D., Ph.D.; Reiko Horikawa, M.D., Ph.D.; George Werther, M.D., Ph.D.; and Chairman, Ron Rosenfeld, M.D. Dr. Bach is currently the Chief Medical Officer for ShouTi Inc., having recently joined from Ascendis Pharma where he served as Senior Vice President, Endocrine Medical Sciences. Dr. Bach is a pediatric endocrinologist with 30 years of clinical research and pharmaceutical development experience, including...

NEW YORK, July 26, 2021 (GLOBE NEWSWIRE) — Portman Ridge Finance Corporation (NASDAQ: PTMN) (the “Company” or “Portman Ridge”) today provided an update on its previously announced share buyback program. Following the recent lifting of the suspension on repurchases under the share buyback program due to its merger transaction with Harvest Capital Credit Corporation (“HCAP”), the Company has been actively repurchasing its shares under the program. To date, the Company has repurchased approximately $1.1 million of its shares since the closing the HCAP merger transaction on June 9. 2021. The Company expects to continue to conduct buybacks under the program throughout the remainder of the year based on market conditions and other factors, subject to legal and contractual restrictions. As a reminder, on March 11, 2021, the Company’s...

Amendment Extends NDA Acceptance Date PALATINE, Ill., July 26, 2021 (GLOBE NEWSWIRE) — Acura Pharmaceuticals, Inc. (OTCQB: ACUR) today announced an amendment to its License, Development and Commercialization Agreement (“Agreement”) regarding Acura’s LIMITx™ LTX-03 product candidate with Abuse Deterrent Pharma, LLC (“AD Pharma”) to extend the FDA Acceptance Date for LTX-03 (“NDA Acceptance Date”) to February 28, 2022. LTX-03 (hydrocodone with acetaminophen)Recent reports suggest growing numbers of legitimate pain patients are going undertreated as they can no longer find doctors willing to treat them due to new prescribing guidelines associated with the opioid epidemic. Suicide is increasingly seen as the only remedy for some of these patients through opioid overdose. Our goal with LIMITx is to develop a treatment for effective...

MONROE, Mich., July 26, 2021 (GLOBE NEWSWIRE) — La-Z-Boy Incorporated (NYSE: LZB), a global leader in residential furniture, today announced it plans to invest more than $30 million over a two-year period in its Neosho, MO manufacturing facility. The 550,000 square-foot plant, which began operations in 1970 and employs approximately 950 people, makes reclining motion furniture and supports all La-Z-Boy manufacturing operations with metal components and purchased parts. The scope of the project includes various upgrades and renovations throughout the upholstery plant, a new medical clinic for employees and their families, and a new parts distribution center. Melinda D. Whittington, President and Chief Executive Officer, of La-Z-Boy Incorporated, said, “We are making strategic investments across the organization to ensure La-Z-Boy...

NEW YORK, July 26, 2021 (GLOBE NEWSWIRE) — Apollo Commercial Real Estate Finance, Inc. (the “Company” or “ARI”) (NYSE:ARI), today announced the Board of Directors (the “Board”) of the Company elected Pamela Carlton to serve as an independent director, effective July 22, 2021. Ms. Carlton joins a recently expanded ARI Board, following the election earlier this year of Carmencita Whonder at the Company’s Annual Meeting. Ms. Carlton’s election brings the total number of board members to ten, six of whom are independent directors. She will serve as a member of the Compensation Committee. Commenting on the expanded Board, Michael Salvati, non-executive Chairman of the Board of ARI, said: “We are thrilled to welcome Pamela and Carmencita, who joined us earlier this year, to the Board of ARI. Both women are seasoned executives and we...

ANCHORAGE, Alaska, July 26, 2021 (GLOBE NEWSWIRE) — Northrim BanCorp, Inc. (NASDAQ:NRIM) (“Northrim” or the “Company”) today reported net income of $8.35 million, or $1.33 per diluted share, in the second quarter of 2021, compared to $12.18 million, or $1.94 per diluted share, in the first quarter of 2021, and $9.90 million, or $1.52 per diluted share, in the second quarter a year ago.   Fee and interest income from the Small Business Administration’s (“SBA”) Paycheck Protection Program (“PPP”) loans and high levels of production in the Home Mortgage Lending segment contributed to profitability for the quarter. Also benefiting second quarter results was a $427,000 benefit to the provision for credit losses. This compares to a $1.5 million benefit to the provision for credit losses in the...